EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Protective effects of dexpanthenol against diatrizoate-induced contrast nephropathy via the SIRT1–p53–Bcl-2/Bax pathway in rats

Cenk Mustafa Havabulut, Demet Gündüz, Emine Sarman, İlter İlhan, Muhammet Yusuf Tepebaşı, Abdurrahman Gülal, Mehtap Savran, Halil Aşcı

Naunyn-Schmiedeberg's Archives of Pharmacology · 2026

DOI: 10.1007/s00210-026-05520-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, 2026. Verfasst von Cenk Mustafa Havabulut und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Faculty of Medicine, Suleyman Demirel University, Isparta, Turkey. cenkhavabulut@sdu.edu.tr. Hauptthemen laut MEDLINE: Pantothenic Acid, Contrast Media, Kidney Diseases, Diatrizoate. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Suleyman Demirel University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Contrast agents are widely used in medical imaging to improve tissue differentiation, but they can cause serious inflammatory responses, including contrast-induced nephropathy (CIN). Dexpanthenol (DEX) is known for its antioxidant, anti-inflammatory, and anti-apoptotic properties. This study aimed to investigate the potential protective effects of dexpanthenol in a rat model of diatrizoate-induced CIN. In this study, 32 Wistar albino rats were randomly divided into four groups: control, Urografin (URO; 10 mL/kg, intraperitoneal [i.p.]), URO + DEX (500 mg/kg, i.p. for 3 days), and DEX alone. Renal function markers (serum urea and creatinine), total oxidant status (TOS), total antioxidant status (TAS), and oxidative stress index (OSI) were measured. Histopathological evaluation and immunohistochemical analysis of tumor necrosis factor-alpha (TNF-α) and caspase-3 (Cas-3) were performed. Additionally, SIRT1, Bcl-2, Bax, and p53 mRNA expression levels were assessed. URO administration increased TOS and OSI values and caused significant renal histopathological damage. TNF-α and Cas-3 immunoreactivity, along with Bax and p53 gene expression, were significantly elevated, while Bcl-2 and SIRT1 expression was suppressed. DEX treatment provided partial improvement in these changes, contributed to the preservation of renal architecture, and was associated with improvements in biochemical and molecular parameters approaching those of the control levels. In conclusion, DEX may exert nephroprotective effects against CIN by reducing oxidative stress, inhibiting pro-inflammatory and apoptotic pathways, and increasing anti-apoptotic gene expression. These findings provide a preclinical basis supporting the idea that dexpanthenol is a promising candidate for further translational and clinical studies in contrast-induced renal injury.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pantothenic AcidContrast MediaKidney DiseasesDiatrizoateAnti-Inflammatory AgentsAnimalsRats, WistarSirtuin 1Proto-Oncogene Proteins c-bcl-2Tumor Suppressor Protein p53Malebcl-2-Associated X ProteinOxidative StressKidneySignal TransductionApoptosisRatsTumor Necrosis Factor-alpha

Stichwörter der Autor:innen

ApoptosisContrast nephropathyDexpanthenolDiatrizoateOxidative stress

Substanzen

dexpanthenolPantothenic AcidSirtuin 1Bcl2 protein, ratProto-Oncogene Proteins c-bcl-2Contrast MediaTumor Suppressor Protein p53bcl-2-Associated X ProteinBax protein, ratDiatrizoate

Autor:innen und Institutionen

  • Department of Radiology, Faculty of Medicine, Suleyman Demirel University, Isparta, Turkey. cenkhavabulut@sdu.edu.tr.
  • Department of Radiology, Faculty of Medicine, Akdeniz University, Antalya, Turkey.
  • Department of Histology and Embryology, Faculty of Medicine, Afyonkarahisar Health Sciences University, Afyonkarahisar, Turkey.
  • Department of Biochemistry, Faculty of Medicine, Suleyman Demirel University, Isparta, Turkey.
  • Department of Genetics, Faculty of Medicine, Suleyman Demirel University, Isparta, Turkey.
  • Graduate School Of Health Sciences, Suleyman Demirel University, Isparta, Turkey.

Förderung

  • Suleyman Demirel University

Zitieren

APA

Havabulut, C. M., Gündüz, D., Sarman, E., İlhan, İ., Tepebaşı, M. Y., Gülal, A., Savran, M., & Aşcı, H. (2026). Protective effects of dexpanthenol against diatrizoate-induced contrast nephropathy via the SIRT1–p53–Bcl-2/Bax pathway in rats. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-026-05520-5

Vancouver

Havabulut CM, Gündüz D, Sarman E, İlhan İ, Tepebaşı MY, Gülal A, et al. Protective effects of dexpanthenol against diatrizoate-induced contrast nephropathy via the SIRT1–p53–Bcl-2/Bax pathway in rats. Naunyn-Schmiedeberg's Archives of Pharmacology. 2026. doi:10.1007/s00210-026-05520-5

BibTeX
@article{Havabulut2026,
  author = {Havabulut, Cenk Mustafa and Gündüz, Demet and Sarman, Emine and İlhan, İlter and Tepebaşı, Muhammet Yusuf and Gülal, Abdurrahman and Savran, Mehtap and Aşcı, Halil},
  title = {Protective effects of dexpanthenol against diatrizoate-induced contrast nephropathy via the SIRT1–p53–Bcl-2/Bax pathway in rats},
  journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
  year = {2026},
  doi = {10.1007/s00210-026-05520-5}
}
Kostenlos starten →